Klinique Med Valuation
| KLINIQ Stock | 32.75 0.50 1.55% |
At this time, the firm appears to be overvalued. Klinique Med secures a last-minute Real Value of USD27.83 per share. The latest price of the firm is USD32.75. Our model forecasts the value of Klinique Med from analyzing the firm fundamentals such as Current Valuation of 9.44 B, return on asset of 0.12, and Return On Equity of 0.95 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Klinique Med's price fluctuation is very steady at this time. Calculation of the real value of Klinique Med is based on 3 months time horizon. Increasing Klinique Med's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Klinique Med is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Klinique Stock. However, Klinique Med's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 32.75 | Real 27.83 | Hype 32.75 | Naive 34.24 |
The real value of Klinique Stock, also known as its intrinsic value, is the underlying worth of Klinique Med Company, which is reflected in its stock price. It is based on Klinique Med's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Klinique Med's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of The Klinique Med helps investors to forecast how Klinique stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Klinique Med more accurately as focusing exclusively on Klinique Med's fundamentals will not take into account other important factors: Klinique Med Total Value Analysis
The Klinique Med is now forecasted to have takeover price of 9.44 B with market capitalization of 7.81 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Klinique Med fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.44 B | 7.81 B |
Klinique Med Asset Utilization
One of the ways to look at asset utilization of Klinique is to check how much profit was generated for every dollar of assets it reports. The Klinique Med makes use of its assets almost 0.12 %, making 0.12 cents for each dollar of assets held by the firm. A growing asset utilization conveys that the company is being more effective with each dollar of assets it secures. Strictly speaking, asset utilization of Klinique Med shows how effective it operates for each dollar spent on its assets.Klinique Med Ownership Allocation
Klinique Med maintains a total of 220 Million outstanding shares. The Klinique Med secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 73.66 % of The Klinique Med outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Klinique Med's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Klinique Med and how it compares across the competition.
About Klinique Med Valuation
The stock valuation mechanism determines Klinique Med's current worth on a weekly basis. Our valuation model uses a comparative analysis of Klinique Med. We calculate exposure to Klinique Med's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Klinique Med's related companies.8 Steps to conduct Klinique Med's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Klinique Med's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Klinique Med's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Klinique Med's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Klinique Med's revenue streams: Identify Klinique Med's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Klinique Med's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Klinique Med's growth potential: Evaluate Klinique Med's management, business model, and growth potential.
- Determine Klinique Med's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Klinique Med's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Klinique Stock analysis
When running Klinique Med's price analysis, check to measure Klinique Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klinique Med is operating at the current time. Most of Klinique Med's value examination focuses on studying past and present price action to predict the probability of Klinique Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klinique Med's price. Additionally, you may evaluate how the addition of Klinique Med to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets |